Arkolith/Insider Trading/KRBP/Form 4

Hungerford Brian

Chief Financial OfficerKiromic Biopharma, Inc. (KRBP) · full profile →Form 4 · filed Aug 21, 2024
Net Buying
Open-Market Buys
$9K
Open-Market Sells
$0
Net Open-Market Flow
$9K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 20, 2024Buy(P)4K$2.20$8K65K
Aug 19, 2024Buy(P)258$2.25$58161K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-027492) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML